Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).
This report elaborates on the current development of the Ponatinib Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
ARIAD Pharmaceuticals
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
45mg
15mg
Application:
CML
ALL
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Ponatinib Drugs Industry Overview
-
1.1.1 Ponatinib Drugs Market Scope and Market Segments
-
1.1.2 Ponatinib Drugs Industry Characteristics
-
1.1.3 Global and China Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Ponatinib Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Ponatinib Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 45mg
-
1.2.2 15mg
-
1.3 Global Ponatinib Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 CML
-
1.3.2 ALL
-
1.4 Market Analysis by Region
-
1.4.1 North America Ponatinib Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Ponatinib Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Ponatinib Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Ponatinib Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Ponatinib Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Ponatinib Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Ponatinib Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Ponatinib Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Ponatinib Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Ponatinib Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Ponatinib Drugs Industry PEST Analysis
-
2.3 Ponatinib Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Ponatinib Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Ponatinib Drugs Industry
Chapter 3 Global and China Ponatinib Drugs Market, by Manufacturer
-
3.1 Global and China Ponatinib Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Ponatinib Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Ponatinib Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Ponatinib Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Ponatinib Drugs Market Top 3 Players
Chapter 4 Global and China Ponatinib Drugs Market, by Type (2017-2028)
-
4.1 Ponatinib Drugs Market Trend, by Type
-
4.2 Global Ponatinib Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Ponatinib Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Ponatinib Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Ponatinib Drugs Price Trend, by Type (2017-2028)
-
4.3 China Ponatinib Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Ponatinib Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Ponatinib Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Ponatinib Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Ponatinib Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Ponatinib Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Ponatinib Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Ponatinib Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Ponatinib Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Ponatinib Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Ponatinib Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Ponatinib Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Ponatinib Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Ponatinib Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Ponatinib Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Ponatinib Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Ponatinib Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Ponatinib Drugs Market Analysis
-
7.1 North America Ponatinib Drugs Market, by Type
-
7.2 North America Ponatinib Drugs Market, by Application
-
7.3 North America Ponatinib Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Ponatinib Drugs Market Analysis
-
8.1 Europe Ponatinib Drugs Market, by Type
-
8.2 Europe Ponatinib Drugs Market, by Application
-
8.3 Europe Ponatinib Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Ponatinib Drugs Market Analysis
-
9.1 APAC Ponatinib Drugs Market, by Type
-
9.2 APAC Ponatinib Drugs Market, by Application
-
9.3 APAC Ponatinib Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Ponatinib Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Ponatinib Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Ponatinib Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Ponatinib Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Ponatinib Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Ponatinib Drugs Company Profiles
-
11.1 ARIAD Pharmaceuticals
-
11.1.1 ARIAD Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 ARIAD Pharmaceuticals Ponatinib Drugs Product Profiles, Application and Specification
-
11.1.3 ARIAD Pharmaceuticals Ponatinib Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Ponatinib Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Ponatinib Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Ponatinib Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Ponatinib Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Ponatinib Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Ponatinib Drugs Market Size and Growth Rate of 45mg (2017-2028)
-
Figure Global Ponatinib Drugs Market Size and Growth Rate of 15mg (2017-2028)
-
Figure Global Ponatinib Drugs Market Size and Growth Rate of CML (2017-2028)
-
Figure Global Ponatinib Drugs Market Size and Growth Rate of ALL (2017-2028)
-
Figure North America Ponatinib Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Ponatinib Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Ponatinib Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Ponatinib Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Ponatinib Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Ponatinib Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Ponatinib Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Ponatinib Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Ponatinib Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Ponatinib Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Ponatinib Drugs Market Share, by Manufacturer in 2022
-
Table Global Ponatinib Drugs Sales Volume, by Type (2017-2028)
-
Table Global Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Ponatinib Drugs Sales Value, by Type (2017-2028)
-
Table Global Ponatinib Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Ponatinib Drugs Price Trend, by Type (2017-2028)
-
Table China Ponatinib Drugs Sales Volume, by Type (2017-2028)
-
Table China Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Ponatinib Drugs Sales Value, by Type (2017-2028)
-
Table China Ponatinib Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Ponatinib Drugs Price Trend, by Type (2017-2028)
-
Table Global Ponatinib Drugs Sales Volume, by Application (2017-2028)
-
Table Global Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Ponatinib Drugs Sales Value, by Application (2017-2028)
-
Table Global Ponatinib Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Ponatinib Drugs Sales Value Share, by Application (2017-2028)
-
Table China Ponatinib Drugs Sales Volume, by Application (2017-2028)
-
Table China Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Ponatinib Drugs Sales Value, by Application (2017-2028)
-
Table China Ponatinib Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Ponatinib Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Ponatinib Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Ponatinib Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Ponatinib Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Ponatinib Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Ponatinib Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Ponatinib Drugs Sales Volume, by Type (2017-2028)
-
Table North America Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Ponatinib Drugs Sales Volume, by Application (2017-2028)
-
Table North America Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Ponatinib Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Ponatinib Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Ponatinib Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Ponatinib Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Ponatinib Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Ponatinib Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Ponatinib Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Ponatinib Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Ponatinib Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Ponatinib Drugs Sales Value and Growth Rate (2017-2028)
-
Table ARIAD Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table ARIAD Pharmaceuticals Product Profiles, Application and Specification
-
Table ARIAD Pharmaceuticals Ponatinib Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
